The number of health care providers with waivers to prescribe buprenorphine for opioid use disorder increased 19% between October 2021 and September 2022 to 132,005, the Department of Health and Human Services announced today. HHS last April issued revised practice guidelines for administering buprenorphine to treat OUD, which eased requirements for clinicians to obtain a waiver to treat OUD patients with buprenorphine. According to HHS, pharmacy-filled prescriptions for the overdose reversal drug naloxone also increased 37% over the period, from a three-month average of 109,414 prescriptions in October 2021 to 150,213 in August 2022. 
 

Headline
The Department of Labor released an enforcement alert Nov. 13 to employers and health plan fiduciaries to ensure that plan participants and beneficiaries are…
Headline
The Centers for Medicare & Medicaid Services Nov. 13 announced it will delay enforcement of its Medicaid community engagement requirements that are set for…
Headline
The Department of Health and Human Services Nov. 12 made two announcements  regarding the development of mental health treatments for veterans and other…
Headline
A study on substance-related emergency department visits and hospitalizations published Nov. 4 by The American Journal of Psychiatry found that cannabis was…
Headline
Bill Gassen, president and CEO of Sanford Health and AHA chair-elect, will participate in a panel discussion during the 2026 Milken Institute Future of Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…